NSE: APOLLOHOSP · 13 October 2026
- Apollo Hospitals Enterprise Limited (APOLLOHOSP) shares are trading lower today, down 2.27% at ₹7,845.50 compared to the previous close of ₹8,027.50. The stock opened at ₹7,755.00 and has so far moved within a day's range of ₹7,688.00 and ₹7,847.50.
- Apollo Hospitals Enterprise Limited announced that its Board of Directors approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as the new statutory auditors for a five-year term starting from the conclusion of the 46th Annual General Meeting in 2027 until 2032. Current auditors Deloitte Haskins & Sells LLP will continue to audit the company until the 2027 AGM. This transition follows standard governance rotation guidelines.
- Trading volume was 0.11 times the 20-day average daily volume.
Why is Apollo Hospitals Enter. L share price falling on 13 October 2026?
Apollo Hospitals Enterprise Limited (APOLLOHOSP) shares are trading lower today, down 2.27% at ₹7,845.50 compared to the previous close of ₹8,027.50. The stock opened at ₹7,755.00 and has so far moved within a day's range of ₹7,688.00 and ₹7,847.50.
In broader market context, the benchmark Nifty rose 0.56%, whereas the Nifty Pharma sector index declined 0.39%. Apollo's drop of 2.27% underperformed both the wider market and its immediate sector benchmark. The stock has experienced recent pressure, down 1.75% over the past 5 trading days and 11.85% over the past 20 trading days, following a prior session return of 4.72%.
Company disclosures from August 2026 outline ongoing strategic developments, including the pending Composite Scheme of Arrangement for the demerger of its omni-channel pharmacy distribution and digital health platform business into Apollo Healthtech Limited, alongside board approval for the appointment of Price Waterhouse Chartered Accountants LLP as statutory auditors commencing from 2027. While these corporate restructuring updates provide longer-term context regarding the company's vertically integrated model, no single confirmed operational trigger was identified to directly account for today's price movement.
67,819 shares traded by 13 October 2026 · 09:35 AM IST. This compares with a 20-day average daily volume of 6.17 lakh shares (0.11 times). The five-day average daily volume was 9.78 lakh shares. Separately, the NSE report for 12 October 2026 showed 6.24 lakh shares delivered, representing 62.97% of that day’s traded volume. The same report recorded 81,953 trades.
With no same-day operational catalysts or announcements directly linking to today's decline, the 2.27% drop appears consistent with a technical pullback and profit-taking following recent volatility, occurring on thin trading volumes well below 20-day averages.
Latest Company Developments
Apollo Hospitals Enterprise Limited announced that its Board of Directors approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as the new statutory auditors for a five-year term starting from the conclusion of the 46th Annual General Meeting in 2027 until 2032. Current auditors Deloitte Haskins & Sells LLP will continue to audit the company until the 2027 AGM. This transition follows standard governance rotation guidelines.
Ensures seamless continuity and transparency in financial reporting over the medium term.
The company provided updates on its ongoing Composite Scheme of Arrangement involving Apollo Healthco Limited and Keimed Private Limited. The scheme provides for the demerger of the omni-channel pharmacy distribution and digital health platform business into Apollo Healthtech Limited, with subsequent listing on the NSE and BSE. Petitions have been filed before the National Company Law Tribunal following requisite creditor and shareholder approvals.
Unlocks value by separating the high-growth digital and pharmacy distribution verticals from core hospital operations.
The board took note of a proposed transfer by Apollo Healthco Limited of its wholesale fast-moving consumer goods, wellness, and personal care distribution undertaking to Apollo Consumer Products Limited on a slump sale basis, subject to shareholder approval. The move reorganizes non-prescription consumer healthcare product lines under a dedicated subsidiary structure.
Streamlines operational focus within the retail and distribution segments.
a press release dated August 12, 2026, titled "Apollo Hospitals Q1FY27 Results".
Proceedings of Court Convened General Meeting held on Jun 24, 2026 along with a copy of minutes.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 17.19% on 30 September 2026. This compares with 17.33% on 30 June 2026, a change of -0.14 percentage points.
The filing reported 406 MF/UTI holders.
What to Watch Next
- Progression of the NCLT petition regarding the Composite Scheme of Arrangement for Apollo Healthtech
- Execution and operational scaling of the digital health platform Apollo 24/7 and pharmacy distribution segments
- Delivery volume trends and cash-market participation relative to the 20-day average volume
- Quarterly financial performance updates ahead of the upcoming board meeting scheduled for November 4, 2026
Other Dated Coverage
- Why Apollo Hospitals Shares Fell 0.88% Today | 6 October 2026 — 6 October 2026
- Why Apollo Hospitals Shares Are Falling 2.44% Today | 1 October 2026 — 1 October 2026
- Why Apollo Hospitals Shares Dropped 6.64% Today: Heavy Volume Selloff | 30 September 2026 — 30 September 2026
More Apollo Hospitals Enter. L news and dated analysis →
Frequently Asked Questions
What is the latest Apollo Hospitals Enter. L company news?
Apollo Hospitals Enterprise Limited announced that its Board of Directors approved the appointment of M/s Price Waterhouse Chartered Accountants LLP as the new statutory auditors for a five-year term starting from the conclusion of the 46th Annual General Meeting in 2027 until 2032. Current auditors Deloitte Haskins & Sells LLP will continue to audit the company until the 2027 AGM. This transition follows standard governance rotation guidelines.
How strong was Apollo Hospitals Enter. L’s trading volume?
67,819 shares traded, 0.11 times the 20-day average daily volume. The price and volume data are dated 13 October 2026 · 09:35 AM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.